Hims & Hers Health, Inc.
HIMSUS売上高
$2.3B
百万USD
営業利益
$106M
百万USD
純利益
$128M
百万USD
ROE
23.7%
最新FY
EPS
$0.51
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $52M | $-51M | $-0.34 |
| FY2021 | Q2 | $61M | $-9M | $-0.05 |
| FY2021 | Q3 | $74M | $-16M | $-0.08 |
| FY2021 | FY | $272M | $-108M | $-0.58 |
| FY2022 | Q1 | $101M | $-16M | $-0.08 |
| FY2022 | Q2 | $114M | $-20M | $-0.10 |
| FY2022 | Q3 | $145M | $-19M | $-0.09 |
| FY2022 | FY | $527M | $-66M | $-0.32 |
| FY2023 | Q1 | $191M | $-10M | $-0.05 |
| FY2023 | Q2 | $208M | $-7M | $-0.03 |
| FY2023 | Q3 | $227M | $-8M | $-0.04 |
| FY2023 | FY | $872M | $-24M | $-0.11 |
| FY2024 | Q1 | $278M | $11M | $0.05 |
| FY2024 | Q2 | $316M | $13M | $0.06 |
| FY2024 | Q3 | $402M | $76M | $0.32 |
| FY2024 | FY | $1.5B | $126M | $0.53 |
| FY2025 | Q1 | $586M | $49M | $0.20 |
| FY2025 | Q2 | $545M | $43M | $0.17 |
| FY2025 | Q3 | $599M | $16M | $0.06 |
| FY2025 | FY | $2.3B | $128M | $0.51 |
| FY2026 | Q1 | $608M | $-92M | $-0.40 |
財務データ
| 指標 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $272M | $527M | $872M | $1.5B | $2.3B |
| 営業利益 | - | $-5M | $-115M | $-69M | $-29M | $62M | $106M |
| 純利益 | - | $-3M | $-108M | $-66M | $-24M | $126M | $128M |
| 総資産 | $205M | $206M | $421M | $366M | $441M | $708M | $2.2B |
| 純資産 | - | - | - | - | - | - | - |
| 自己資本 | $5M | $5M | $335M | $312M | $344M | $477M | $541M |
| 営業CF | - | $-1M | $-34M | $-27M | $73M | $251M | $300M |
| EPS | - | - | $-0.58 | $-0.32 | $-0.11 | $0.53 | $0.51 |
| BPS | - | - | - | - | - | - | - |
| ROE | - | -61.0% | -32.2% | -21.1% | -6.8% | 26.4% | 23.7% |